{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:36:22Z","timestamp":1790217382477,"version":"4.1.0"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10103-020-03130-y","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T07:03:01Z","timestamp":1599116581000},"page":"989-993","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Role of LASERS in stage 4A retinopathy of prematurity (ROP)"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3170-955X","authenticated-orcid":false,"given":"Shilpi H.","family":"Narnaware","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant K.","family":"Bawankule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,3]]},"reference":[{"issue":"2","key":"3130_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00417-016-3443-6","volume":"255","author":"EA Sukgen etal","year":"2017","unstructured":"Sukgen etal EA (2017) Treatment for stage 4A retinopathy of prematurity: laser and\/or ranibizumab. Graefes Arch Clin Exp Ophthalmol 255(2):263\u2013269","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3130_CR2","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","unstructured":"International Committee for the Classification of Retinopathy of Prematurity (2005) The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 123:991\u2013999","journal-title":"Arch Ophthalmol"},{"key":"3130_CR3","first-page":"365","volume":"101","author":"B Mueller","year":"2017","unstructured":"Mueller B et al (2017) Treatment of type I ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone. Br J Ophthalmol 101:365\u2013370","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"3130_CR4","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/j.ophtha.2014.12.017","volume":"122","author":"Hwang","year":"2015","unstructured":"Hwang et al (2015) Outcomes after Intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: a 5-year retrospective analysis. Ophthalmology 122(5):1008\u20131001","journal-title":"Ophthalmology"},{"key":"3130_CR5","unstructured":"Trese et al (2004) A fresh outlook on stage 4A ROP. Retinal Physician."},{"key":"3130_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S0161-6420(97)30325-X","volume":"104","author":"PJ Ferrone","year":"1997","unstructured":"Ferrone PJ, Harrison C, Trese MT (1997) Lens clarity after lens-sparing vitrectomy in a pediatric population. Ophthalmology. 104:273\u2013278","journal-title":"Ophthalmology."},{"key":"3130_CR7","first-page":"3136","volume":"50","author":"W-C Wu","year":"2009","unstructured":"Wu W-C et al (2009) Vitrectomy for stage 4A retinopathy of prematurity (ROP). Invest Ophthalmol Vis Sci 50:3136","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3130_CR8","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ophtha.2010.04.018","volume":"118","author":"W Wu","year":"2011","unstructured":"Wu W, Yeh P, Yang C et al (2011) Effects and Complications of bevacizmab use in patients with retinopathy of prematurity: a multicenter study in Taiwan. Ophthalmology 118:176\u2013183","journal-title":"Ophthalmology"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-020-03130-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-020-03130-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-020-03130-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T22:50:04Z","timestamp":1630709404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-020-03130-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["3130"],"URL":"https:\/\/doi.org\/10.1007\/s10103-020-03130-y","relation":{},"ISSN":["0268-8921","1435-604X"],"issn-type":[{"value":"0268-8921","type":"print"},{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,3]]},"assertion":[{"value":"29 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participant parents included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Taken from parents.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}